Personalized vaccine for lymphoma patients extends disease-free survival by nearly 2 years
(ORLANDO, Fla.) — A personalized vaccine is a powerful therapy to prevent recurrence among certain follicular lymphoma patients, according to the latest results of ongoing research led by the University of Pennsylvania School of Medicine. The new …